Radiofrequency treatment is an effective option for treating refractory chronic knee, hip, and shoulder joint pain associated with osteoarthritis.
A review and meta-analysis indicates that spinal manipulative therapy is linked to modest improvements in low back pain.
The Veterans Administration and Department of Defense issue an updated clinical practice guideline regarding opioid therapy for chronic pain in veterans.
Researchers found a correlation between use of corticosteroids and increased odds of metabolic syndrome and elevated body mass index.
FDA gives breakthrough therapy designation to rituxan for treatment of pemphigus vulgaris and is indicated for treating rheumatoid arthritis
Anthony Mariano, PhD, gives insight into dealing with patients' demands for opioids.
A single glucocorticoid intradiscal injection will reduce chronic low back pain with active discopathy for 1 month but not 12 months after injection.
New opioid analgesic, NKTR-181, being evaluated in the SUMMIT-07 Phase 3 study for the treatment of moderate to severe chronic pain.
Researchers found that prescribing opioids to patients for 8 or more days increases likelihood of long-term dependence.
Study examines cohort of consecutive patients treated with 3D neural targeting spinal cord stimulation vs patients previously treated with a traditional SCS device.
Heroin accounted for one-quarter of overdose deaths in 2015.
Updated guidelines for chronic, non-cancer pain focus on safe and effective opioid prescribing practices.
Increasing evidence supports the notion that an individual's specific response to pain or pain treatments may be affected by particular gene polymorphisms.
No difference in health care utilization was seen in patients receiving early PT for a new episode of low back pain compared with those not receiving PT.
Randomized trial evaluates improvements in pain and function using internet-based in-home exercise and pain-coping skills training.
An interview with Penney Cowan, founder and chief executive officer of the American Chronic Pain Association, where she discusses the ACPA's publication aimed at helping healthcare practitioners improve care of patients with chronic pain.
New practice guidelines on the noninvasive treatment of low back pain have been issued by the American College of Physicians (ACP).
Study suggests that functioning and pain interference should be routinely assessed in children with chronic pain.
Review of studies finds small improvements in pain levels and function after 3 to 6 months of yoga.
Methods to prevent depression could help reduce chronic back pain.
Only 1 in 6 patients who take NSAIDs for back pain achieved benefits from the therapy.
The FDA has given its approval for 26-week treatment efficacy claims for Zimmer Biomet's knee osteoarthritis product.
Spinal cord stimulation was found to help decrease or stabilize opioid use in patients with chronic pain.
The National Academies of Sciences, Engineering, and Medicine has released a report on cannabis and cannabinoids, outlining current knowledge and giving recommendations for future research.
The updated guidelines address guidance on dosing, including reduced starting and maintenance dosing, and safety precautions for diagnosing and treating complications.
Due to the prevalence of prescription opioid abuse in the United States, the development of abuse-resistant pain medications has been a focus for many pharmaceutical companies.
Researchers examined whether or not the weather truly affects episodes of acute low back pain.
A retrospective cohort study found 1 in 5 non-steroidal anti-inflammatory drug (NSAID) adverse drug reactions is a hypersensitivity reaction.
Study finds improvement in self-reported outcomes at 3 months and longer in patients with chronic lumbar back pain.
Similar efficacy, superior safety of nonparticulate vs particulate corticosteroids for alleviating radicular pain.
Rheumatology Advisor Articles
- Rheumatoid Arthritis Increases Mortality Risk in Staphylococcus aureus Infections
- First Clinical Practice Guidelines for Sjögren's Syndrome Developed
- Antibiotic Resistance Problem Brought Before Congress
- FDA Delays Approval of JAK Inhibitor Baricitinib
- How Effective is RF Denervation for Symptomatic Knee OA?
- Allopurinol Use In Concomitant Gout and Diabetes Lowers Cardiovascular Event Risk
- Measuring Disease Activity in Psoriatic Arthritis
- JAK/STAT Inhibitors: A New Treatment Target for Rheumatoid Arthritis
- Biosimilar Confidence: Physician-Patient Communication Sets the Tone
- VA and DoD Practice Guideline Update: Opioids for Chronic Pain
- Leg Positioning During Lumbar DXA Does Not Impact Trabecular Bone Scores
- Should Trabecular Bone Score Be Used to Predict Fragility Fracture Risk in T1D?
- DXA for Pediatric Bone Age Assessment Yields Similar Results vs Traditional Radiography
- Remote Osteoporosis Specialist Mentoring Program Improves Physician Self-Confidence
- Increased Costs Associated With Specialists Providing Primary Care